Negotiations for lower drugs prices are at risk again — this time in the courts ...Middle East

Back in 2003, when the Medicare prescription drug benefit was enacted into law, the pharmaceutical industry bought a sweetheart deal. The chairman of a key committee, Billy Tauzin, inserted into the bill a prohibition on Medicare negotiating directly with drug companies for lower prices. Shortly thereafter, Tauzin left Congress and went to work for the powerful industry trade association (PhRMA) for a salary of $2 million a year. For almost 20 years, PhRMA fought successfully to keep that sweetheart deal. Drug companies could dictate the prices of medicines, and the government could not negotiate directly to get a better deal. That changed last year with passage of the Inflation Red

Hence then, the article about negotiations for lower drugs prices are at risk again this time in the courts was published today ( Wednesday 16/08/2023 - 02:41 PM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Negotiations for lower drugs prices are at risk again — this time in the courts )

Also on site :

• Trump claims doubled gas prices are ‘way down’ as his transport chief tells Americans to take road trips
• Sewage treatment and desalination: Saudi Arabia’s core infrastructure opportunity – World Construction Network
• 1975 Soft Rock Classic, Originally Disliked by '70s Songwriter, Became a No. 1 Hit